• USANA Health Sciences net earnings attributable to shareholders fell 20.1% to USD 7.5 million in first quarter ended April 4, 2026, with diluted EPS down to USD 0.41.
• Net sales edged up 0.3% to USD 250.2 million, as Rise climbed to USD 13.7 million from Protein Pop rollout, offset by Core Nutritional decline to USD 204.4 million and Hiya drop to USD 32.2 million.
• Gross margin narrowed 2.8 percentage points to 76.2%, reflecting a lower-margin sales mix shift toward Rise and weaker Core Nutritional margins.
• Core Nutritional active customers fell 12% to 404,000, while Hiya active monthly subscribers slipped to 186,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000896264-26-000034), on May 12, 2026, and is solely responsible for the information contained therein.